Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)
CUSIP: 603380205
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 45,675,986
- Total 13F shares
- 36,602,211
- Share change
- +9,020,632
- Total reported value
- $220,560,449
- Price per share
- $6.02
- Number of holders
- 41
- Value change
- +$54,426,934
- Number of buys
- 21
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 603380205:
Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13D/G
13F
|
Company |
20%
|
9,392,275
|
$35,502,800 | +$30,394,980 | 22 Dec 2025 | |
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
— |
10%
|
8,591,572
|
$32,476,142 | $0 | 23 Dec 2025 | |
| Coastlands Capital LP |
13D/G
|
— |
10%
|
4,563,031
|
$18,571,536 | $0 | 13 Feb 2026 | |
| Logos Global Management LP |
13D/G
13F
|
Company |
9.9%
|
4,435,444
|
$18,407,093 | $0 | 23 Dec 2025 | |
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
10%
|
4,539,854
|
$18,250,213 | $0 | 31 Dec 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
9.5%
|
4,322,747
|
$17,377,443 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
9.9%
from 13D/G
|
9,000
|
$17,146,920 | — | 31 Dec 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
6.4%
|
2,838,000
|
$11,777,700 | $0 | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6.2%
|
2,838,000
|
$11,408,760 | — | 31 Dec 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.2%
|
2,365,000
|
$9,507,300 | — | 31 Dec 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
3.6%
|
1,655,500
|
$6,655,110 | — | 31 Dec 2025 | |
| Spruce Street Capital LP |
13F
|
Company |
3.6%
|
1,655,500
|
$6,655,110 | — | 31 Dec 2025 | |
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,275,000
|
$4,794,000 | — | 27 Jun 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
1.6%
|
709,500
|
$2,852,190 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.55%
|
252,029
|
$1,013,156 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
149,200
|
$599,784 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.3%
|
137,911
|
$554,402 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.16%
|
72,669
|
$292,129 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
69,919
|
$281,133 | — | 31 Dec 2025 | |
| Apella Capital, LLC |
13F
|
Company |
0.09%
|
42,380
|
$170,368 | — | 31 Dec 2025 | |
| Lion Point Capital, LP |
13F
|
Company |
0.08%
|
35,000
|
$140,700 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
24,019
|
$96,556 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
22,294
|
$89,622 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
11,055
|
$44,441 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
10,579
|
$42,000 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,240
|
$9,000 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,807
|
$7,264 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
1,500
|
$6,030 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
501
|
$2,014 | — | 31 Dec 2025 | |
| CWM, LLC |
13F
|
Company |
0%
|
420
|
$2,000 | — | 31 Dec 2025 | |
| Larson Financial Group LLC |
13F
|
Company |
0%
|
400
|
$1,608 | — | 31 Dec 2025 | |
| Fortitude Family Office, LLC |
13F
|
Company |
0%
|
303
|
$1,218 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
251
|
$1,009 | — | 31 Dec 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
100
|
$402 | — | 31 Dec 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
100
|
$402 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
62
|
$249 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
51
|
$205 | — | 31 Dec 2025 | |
| Anchor Investment Management, LLC |
13F
|
Company |
0%
|
12
|
$48 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13D/G
|
— |
10%
|
4,323,112
|
— | $0 | 31 Mar 2026 | |
| Remy Luthringer |
3/4/5
|
CEO, Director |
—
class O/S missing
|
2,250,000
|
— | — | 22 Dec 2025 | |
| Boehringer AG |
13D/G
|
— |
3.4%
|
1,500,225
|
— | $0 | 23 Dec 2025 | |
| Geoff Race |
3/4/5
|
President |
—
class O/S missing
|
1,500,000
|
— | — | 22 Dec 2025 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
605,230
|
— | — | 11 Aug 2022 | |
| Frederick W. Ahlholm |
3/4/5
|
SVP, CFO and Secretary |
—
class O/S missing
|
500,000
|
— | — | 22 Dec 2025 | |
| David Kupfer |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 Dec 2025 | |
| Fouzia Laghrissi-Thode |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 Dec 2025 | |
| Hans Peter Hasler |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 Dec 2025 | |
| VAN HEEK G JAN |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 Dec 2025 | |
| Jeryl L. Hilleman |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 27 Sep 2023 | |
| Inderjit Kaul |
3/4/5
|
Director |
—
class O/S missing
|
12,169
|
— | — | 31 Mar 2026 |
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q1 2026
As of 31 Mar 2026,
Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,602,211 shares.
The largest 10 holders included
FEDERATED HERMES, INC., Vivo Capital, LLC, JANUS HENDERSON GROUP PLC, Balyasny Asset Management L.P., Logos Global Management LP, FARALLON CAPITAL MANAGEMENT LLC, Foresite Capital Management VI LLC, VANGUARD CAPITAL MANAGEMENT LLC, Spruce Street Capital LP, and Trails Edge Capital Partners, LP.
This page lists
41
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
29
Q1 2026 holders
41
Holder diff
12
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.